Mr. Jim Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTCQB:NDATF) PROVIDES A PROGRESS UPDATE TO THE PREVIOUSLY-ANNOUNCED REVERSE TAKEOVER ("RTO")

Ndatalyze Corp. and ThriveTech Holdings remain committed to completing the previously announced reverse takeover. Conversations are continuing with the Canadian Securities Exchange related to various matters in advance of signing the formal binding agreement. To the corporation's knowledge, the primary outstanding issue relates to the postreverse takeover ratio of shares held by prereverse takeover Ndatalyze shareholders versus the percentage of shares held by the new incoming shareholders. While Ndatalyze management is seeking to accelerate the resolution of all issues, the resolution time frame remains unknown.

On the technical side, work progresses toward releasing a new product line that addresses the electronic medical record market, the concierge medical market and the performance coaching market. The new offering, called Sigmund, incorporates Ndatalyze's expert-guided, artificial-intelligence-augmented mental condition assessment and a proprietary DNA panel containing numerous scientifically identified mental condition markers. Sigmund is essentially complete with the final reports and new website in the final stages.

We seek Safe Harbor.